Submissions for variant NM_001369.3(DNAH5):c.1672A>G (p.Thr558Ala)

gnomAD frequency: 0.34505  dbSNP: rs1530498

Total submissions: 11

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine	RCV000150488	SCV000197674	benign	not specified	2013-02-21	criteria provided, single submitter	clinical testing	Thr558Ala in exon 13 of DNAH5: This variant is not expected to have clinical sig nificance because it has been identified in 40.6% (3481/8584) of European Americ an chromosomes from a broad population by the NHLBI Exome Sequencing Project (ht tp://evs.gs.washington.edu/EVS; dbSNP rs1530498).
PreventionGenetics, part of Exact Sciences	RCV000150488	SCV000307719	benign	not specified		criteria provided, single submitter	clinical testing
Illumina Laboratory Services, Illumina	RCV001095034	SCV000453267	benign	Primary ciliary dyskinesia 3	2018-01-13	criteria provided, single submitter	clinical testing	This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Labcorp Genetics (formerly Invitae), Labcorp	RCV000394892	SCV001000008	benign	Primary ciliary dyskinesia	2024-02-01	criteria provided, single submitter	clinical testing
Pars Genome Lab	RCV001095034	SCV001738702	benign	Primary ciliary dyskinesia 3	2021-06-15	criteria provided, single submitter	clinical testing
GeneDx	RCV001705993	SCV001881051	benign	not provided	2018-11-28	criteria provided, single submitter	clinical testing
Ambry Genetics	RCV000394892	SCV002706151	benign	Primary ciliary dyskinesia	2014-11-26	criteria provided, single submitter	clinical testing	This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Breakthrough Genomics, Breakthrough Genomics	RCV001705993	SCV005306085	benign	not provided		criteria provided, single submitter	not provided
Natera, Inc.	RCV000394892	SCV001462538	benign	Primary ciliary dyskinesia	2020-09-16	no assertion criteria provided	clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen	RCV000150488	SCV001742356	benign	not specified		no assertion criteria provided	clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center	RCV000150488	SCV001970819	benign	not specified		no assertion criteria provided	clinical testing